Business Segments · Expenditures for long-lived assets
Reportable Segment — Expenditures for long-lived assets
Eli Lilly Reportable Segment — Expenditures for long-lived assets decreased by 14.5% to $2.44B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 60.7%, from $1.52B to $2.44B. Over 3 years (FY 2022 to FY 2025), Reportable Segment — Expenditures for long-lived assets shows an upward trend with a 55.9% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026Apr 30, 2026
Rolls up toProperty, plant, and equipment additions
How to read this metric
High levels of expenditure suggest confidence in future demand and a commitment to expanding production capacity.
Detailed definition
Measures the capital invested by the segment into tangible or intangible assets expected to provide benefits over multip...
Peer comparison
Comparable to capital expenditures (CapEx) allocated to specific business segments in industrial and pharma sectors.
Metric ID:
lly_segment_reportable_segment_expenditures_for_long_lived_assetsHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $572.30M | $572.30M | $572.30M | $572.30M | $957.50M | $957.50M | $957.50M | $957.50M | $1.06B | $1.40B | $1.47B | $1.63B | $1.52B | $1.99B | $2.32B | $2.85B | $2.44B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +67.3% | +0.0% | +0.0% | +0.0% | +10.7% | +32.2% | +4.6% | +11.5% | -7.2% | +30.9% | +16.9% | +22.9% | -14.5% |
| YoY Change | — | — | — | — | +67.3% | +67.3% | +67.3% | +67.3% | +10.7% | +46.3% | +53.1% | +70.7% | +43.2% | +41.7% | +58.3% | +74.4% | +60.7% |
Range$572.30M – $2.85B
CAGR+43.7%
Avg YoY Growth+56.0%
Median YoY Growth+60.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's reportable segment — expenditures for long-lived assets?
- Eli Lilly (LLY) reported reportable segment — expenditures for long-lived assets of $2.44B in Q1 2026.
- How has Eli Lilly's reportable segment — expenditures for long-lived assets changed year-over-year?
- Eli Lilly's reportable segment — expenditures for long-lived assets increased by 60.7% year-over-year, from $1.52B to $2.44B.
- What is the long-term trend for Eli Lilly's reportable segment — expenditures for long-lived assets?
- Over 3 years (2022 to 2025), Eli Lilly's reportable segment — expenditures for long-lived assets has grown at a 55.9% compound annual growth rate (CAGR), from $2.29B to $8.67B.
- What does reportable segment — expenditures for long-lived assets mean?
- Capital spending on long-term assets like facilities and equipment for the segment.